View in EDS

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.

Saved in:
Bibliographic Details
Title: Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.
Authors: Banerjee R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Richards A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Midha S; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Afrough A; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Anwer F; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Atanackovic D; Division of Hematology/Oncology, University of Maryland, Baltimore, MD., Atrash S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Bachanova V; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN., Beitinjaneh AM; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL., Bhurtel E; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS., Castaneda Puglianini O; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Chhabra S; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ., Cicero KI; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Davis JA; Department of Pharmacy, Medical University of South Carolina, Charleston, SC., Dhakal B; Division of Hematology, Medical College of Wisconsin, Milwaukee, WI., Dima D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Forsberg PA; Division of Hematology/Oncology, Colorado Blood Cancer Institute, Denver, CO., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Herr MM; Division of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Jain T; Division of Hematology/Oncology, Johns Hopkins University, Baltimore, MD., Janakiram M; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA., Khouri J; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Kocoglu MH; Division of Hematology/Oncology, University of Maryland, Baltimore, MD., Kumar A; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA., Liu Y; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Locke F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS., Mikkilineni L; Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA., Nadeem O; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Parrondo RD; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL., Pasvolsky O; Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX., Peres LC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Purvey S; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA., Raza S; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Reshef R; Division of Hematology/Oncology, Columbia Irving Medical Center, New York City, NY., Richard S; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY., Rossi AC; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY., Sborov DW; Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS., Wagner CB; Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Zanwar SS; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN., Sidana S; Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA., Patel KK; Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Kumar SK; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN., Lin Y; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN., Martin TG; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA., Voorhees PM; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Anderson LD Jr; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Kaur G; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.
Source: Blood advances [Blood Adv] 2025 May 13; Vol. 9 (9), pp. 2336-2340.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40088469
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Banerjee+R%22">Banerjee R</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Richards+A%22">Richards A</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Midha+S%22">Midha S</searchLink>; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Afrough+A%22">Afrough A</searchLink>; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Anwer+F%22">Anwer F</searchLink>; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Atanackovic+D%22">Atanackovic D</searchLink>; Division of Hematology/Oncology, University of Maryland, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Atrash+S%22">Atrash S</searchLink>; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.<br /><searchLink fieldCode="AU" term="%22Bachanova+V%22">Bachanova V</searchLink>; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Beitinjaneh+AM%22">Beitinjaneh AM</searchLink>; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Bhurtel+E%22">Bhurtel E</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Castaneda+Puglianini+O%22">Castaneda Puglianini O</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Chhabra+S%22">Chhabra S</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Cicero+KI%22">Cicero KI</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Davis+JA%22">Davis JA</searchLink>; Department of Pharmacy, Medical University of South Carolina, Charleston, SC.<br /><searchLink fieldCode="AU" term="%22Dhakal+B%22">Dhakal B</searchLink>; Division of Hematology, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Dima+D%22">Dima D</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Ferreri+CJ%22">Ferreri CJ</searchLink>; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.<br /><searchLink fieldCode="AU" term="%22Forsberg+PA%22">Forsberg PA</searchLink>; Division of Hematology/Oncology, Colorado Blood Cancer Institute, Denver, CO.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Herr+MM%22">Herr MM</searchLink>; Division of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Jain+T%22">Jain T</searchLink>; Division of Hematology/Oncology, Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Janakiram+M%22">Janakiram M</searchLink>; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Khouri+J%22">Khouri J</searchLink>; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Kocoglu+MH%22">Kocoglu MH</searchLink>; Division of Hematology/Oncology, University of Maryland, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Kumar+A%22">Kumar A</searchLink>; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Locke+F%22">Locke F</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22McGuirk+JP%22">McGuirk JP</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Mikkilineni+L%22">Mikkilineni L</searchLink>; Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA.<br /><searchLink fieldCode="AU" term="%22Nadeem+O%22">Nadeem O</searchLink>; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Parrondo+RD%22">Parrondo RD</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Pasvolsky+O%22">Pasvolsky O</searchLink>; Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Peres+LC%22">Peres LC</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Purvey+S%22">Purvey S</searchLink>; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA.<br /><searchLink fieldCode="AU" term="%22Raza+S%22">Raza S</searchLink>; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Reshef+R%22">Reshef R</searchLink>; Division of Hematology/Oncology, Columbia Irving Medical Center, New York City, NY.<br /><searchLink fieldCode="AU" term="%22Richard+S%22">Richard S</searchLink>; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.<br /><searchLink fieldCode="AU" term="%22Rossi+AC%22">Rossi AC</searchLink>; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.<br /><searchLink fieldCode="AU" term="%22Sborov+DW%22">Sborov DW</searchLink>; Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Shune+L%22">Shune L</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Wagner+CB%22">Wagner CB</searchLink>; Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Zanwar+SS%22">Zanwar SS</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA.<br /><searchLink fieldCode="AU" term="%22Patel+KK%22">Patel KK</searchLink>; Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Hansen+DK%22">Hansen DK</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Kumar+SK%22">Kumar SK</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Martin+TG%22">Martin TG</searchLink>; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Voorhees+PM%22">Voorhees PM</searchLink>; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.<br /><searchLink fieldCode="AU" term="%22Anderson+LD+Jr%22">Anderson LD Jr</searchLink>; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Cowan+AJ%22">Cowan AJ</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Kaur+G%22">Kaur G</searchLink>; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 May 13; Vol. 9 (9), pp. 2336-2340.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40088469
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025016131
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2336
    Titles:
      – TitleFull: Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Banerjee R
      – PersonEntity:
          Name:
            NameFull: Richards A
      – PersonEntity:
          Name:
            NameFull: Midha S
      – PersonEntity:
          Name:
            NameFull: Afrough A
      – PersonEntity:
          Name:
            NameFull: Anwer F
      – PersonEntity:
          Name:
            NameFull: Atanackovic D
      – PersonEntity:
          Name:
            NameFull: Atrash S
      – PersonEntity:
          Name:
            NameFull: Bachanova V
      – PersonEntity:
          Name:
            NameFull: Beitinjaneh AM
      – PersonEntity:
          Name:
            NameFull: Bhurtel E
      – PersonEntity:
          Name:
            NameFull: Castaneda Puglianini O
      – PersonEntity:
          Name:
            NameFull: Chhabra S
      – PersonEntity:
          Name:
            NameFull: Cicero KI
      – PersonEntity:
          Name:
            NameFull: Davis JA
      – PersonEntity:
          Name:
            NameFull: Dhakal B
      – PersonEntity:
          Name:
            NameFull: Dima D
      – PersonEntity:
          Name:
            NameFull: Ferreri CJ
      – PersonEntity:
          Name:
            NameFull: Forsberg PA
      – PersonEntity:
          Name:
            NameFull: Freeman CL
      – PersonEntity:
          Name:
            NameFull: Herr MM
      – PersonEntity:
          Name:
            NameFull: Jain T
      – PersonEntity:
          Name:
            NameFull: Janakiram M
      – PersonEntity:
          Name:
            NameFull: Khouri J
      – PersonEntity:
          Name:
            NameFull: Kocoglu MH
      – PersonEntity:
          Name:
            NameFull: Kumar A
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Locke F
      – PersonEntity:
          Name:
            NameFull: McGuirk JP
      – PersonEntity:
          Name:
            NameFull: Mikkilineni L
      – PersonEntity:
          Name:
            NameFull: Nadeem O
      – PersonEntity:
          Name:
            NameFull: Parrondo RD
      – PersonEntity:
          Name:
            NameFull: Pasvolsky O
      – PersonEntity:
          Name:
            NameFull: Peres LC
      – PersonEntity:
          Name:
            NameFull: Purvey S
      – PersonEntity:
          Name:
            NameFull: Raza S
      – PersonEntity:
          Name:
            NameFull: Reshef R
      – PersonEntity:
          Name:
            NameFull: Richard S
      – PersonEntity:
          Name:
            NameFull: Rossi AC
      – PersonEntity:
          Name:
            NameFull: Sborov DW
      – PersonEntity:
          Name:
            NameFull: Shune L
      – PersonEntity:
          Name:
            NameFull: Wagner CB
      – PersonEntity:
          Name:
            NameFull: Zanwar SS
      – PersonEntity:
          Name:
            NameFull: Sidana S
      – PersonEntity:
          Name:
            NameFull: Patel KK
      – PersonEntity:
          Name:
            NameFull: Hansen DK
      – PersonEntity:
          Name:
            NameFull: Kumar SK
      – PersonEntity:
          Name:
            NameFull: Lin Y
      – PersonEntity:
          Name:
            NameFull: Martin TG
      – PersonEntity:
          Name:
            NameFull: Voorhees PM
      – PersonEntity:
          Name:
            NameFull: Anderson LD Jr
      – PersonEntity:
          Name:
            NameFull: Cowan AJ
      – PersonEntity:
          Name:
            NameFull: Kaur G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 05
              Text: 2025 May 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1